Christopher Palmer has been an associate editor at MDedge News since 2017. When he's not tidying grammar, he writes short pieces about breaking FDA announcements and approvals, as well as journal articles. He proudly holds a BA in English and philosophy. Follow him on Twitter @cmacmpalm.
News
FDA approves second drug for thrombocytopenia in liver disease
The approval is only for patients with chronic liver disease who are scheduled to undergo either a medical or dental procedure.
News
FDA approves Perseris for schizophrenia
The drug achieved clinically relevant levels without the need for a loading or supplemental doses.
News
FDA approves radioactive agent for adrenal tumors
Iobenguane I 131 injection is indicated for the treatment of rare adrenal tumors that are unresectable, have metastasized, and require systemic...
News
FDA approves Orilissa for endometriosis pain
Orilissa (elagolix) is the first FDA-approved oral treatment for moderate to severe endometriosis pain in more than a decade.
News
FDA approves IDH1 inhibitor for relapsed/refractory AML
The oral medication is the first and only FDA-approved treatment for relapsed/refractory AML with an IDH1 mutation.
News
CREDENCE canagliflozin trial halted because of efficacy
Canagliflozin (Invokana) showed early renal benefits in CREDENCE.
News
FDA approves enzalutamide for non-metastatic CRPC
Approval was based on metastasis-free survival of 36.6 months for those receiving enzalutamide versus 14.7 months for those receiving placebo.
News
AHRQ National Guideline Clearinghouse shutting down
Although some stakeholders are interested in keeping it going, it’s unclear what that would look like and what role, if any, AHRQ would have.
News
FDA grants accelerated approval to ipilimumab/nivolumab combo for CRC
The combo is approved for microsatellite instability-high or mismatch repair deficient metastatic CRC that has progressed.
News
Genentech submits sNDA for venetoclax in untreated AML
The company seeks to treat AML patients ineligible for intensive chemotherapy.
News
FDA gives green light to freeze-dried plasma in combat
Although the FDA is still working to approve the product for general use, it authorized its use in combat-related emergency situations.
News
FDA recommends pooled Zika testing of blood donations
An exception is made for geographic areas with high risk of mosquito-borne Zika transmission.
News
Refusal number fuels sexual hostility in men
The intensity of recorded audio commentary suggested the men took the computer simulation seriously.
News
FDA approves Aristada Initio for schizophrenia
Aristada Initio, a long-acting injectable atypical antipsychotic, is the first on the market to have a 2-month dosing option.
News
FDA approves Zephyr endobronchial valve to treat severe emphysema
“This novel device is a less invasive treatment that expands the options available to patients.”